International Network of VENous Thromboembolism Clinical Research Networks

Flag of France

INNOVTE

Endorsed Studies:

INNOVTE is a national network composed of CHUs, CHGs and private clinics engaged in clinical research on venous thrombosis and pulmonary embolism, grouped around 12 Clinical Investigation Centers, four INSERM units, a reception team and a Biological Resource Center. Our research topics include therapeutic venous thromboembolism, but also diagnostic and prognostic aspects using biomarkers. The presence of several translational research teams also allows us to address more fundamental research questions.

Council Members

Dr. Pierre-Emmanuel Morange

Dr. Pierre-Emmanuel Morange, MD, PhD

Professor Pierre-Emmanuel Morange is the Head of the Department of Haematology in the Centre Hospitalier Universitaire (CHU) Timone, Professor of Haematology in the Faculty of Medicine at the Aix-Marseille University and Director of the Centre de Référence Régional pour l’Exploration des Pathologies Hémorragiques et Thrombotiques (CEHT) at CHU Timone, in Marseille, France. He is also member of the INSERM (UMR_S) 1062 unit, Nutrition Obesity and Risk of Thrombosis, at Aix-Marseille University.

He has special expertise in genetic epidemiology, haemostasis and thrombophilia.

He is member of the steering committee of the INNOVTE consortium and also member of the board of the Groupe Français d’étude sur l’Hémostase et Thrombose (GFHT).

Pr. Francis Couturaud

Pr. Francis Couturaud, MD, PhD

Francis Couturaud is currently Clinical Professor of Respiratory Medicine at Brest University and Head of Department of Respiratory Medicine at Brest University Hospital Center in Brest, France.

He is the director of the research unit “GETBO-EA3878”, dedicated to clinical research and basic science in venous thromboembolism.

He is a member of the French INvestigation Network On Venous Thrombo-Embolism (INNOVTE), a labellised F-CRIN network promoting translational clinical research and European clinical studies on venous thromboembolism.

Dr Couturaud is involved in clinical research on the diagnosis, epidemiology and treatment of pulmonary embolism. He has been involved in many studies on pulmonary embolism published in major journals, especially the PADIS-PE, PADIS-DVT, PEITHO, PREPIC-2, MVTEP trials.

The optimal duration of anticoagulation in patients with venous thromboembolism, particularly in cases of unprovoked venous thromboembolism, is one of his main fields of interest. He is currently conducting the RENOVE trial, a large multicenter randomized controlled trial comparing long term direct oral anticoagulant therapy at full dose versus low dose in patients with venous thromboembolism at high risk of recurrence.

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.